CA
NZ
UK
AU
IND
US
…
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -42.60M | -14.80M | -24.18M | -41.91M |
| Net income | -42.54M | -14.86M | -24.18M | -41.91M |
| Selling general administrative | 11.76M | 12.43M | 7.63M | 7.81M |
| Reconciled depreciation | 0.86M | 0.70M | 0.24M | 0.03M |
| Ebit | - | -30.31M | 4.15M | -59.27M |
| Ebitda | -41.59M | -13.98M | -22.86M | -41.45M |
| Operating income | -44.77M | -30.99M | 4.20M | -59.27M |
| Interest expense | 0.15M | 0.12M | 1.09M | 0.42M |
| Tax provision | -0.06M | 0.06M | - | - |
| Interest income | 0.14M | 0.07M | 0.03M | 0.12M |
| Net interest income | -0.00M | -0.05M | -2.88M | -2.40M |
| Income tax expense | - | 0.06M | - | - |
| Total revenue | 0.00M | 20.09M | 20.00M | 0.00M |
| Total operating expenses | 44.77M | 51.08M | 15.80M | 59.27M |
| Total other income expense net | 2.18M | 16.24M | -25.50M | 19.76M |
| Net income from continuing ops | -42.54M | -14.86M | -24.18M | -41.91M |
| Net income applicable to common shares | - | -14.86M | -24.18M | -41.91M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 7.12M | 47.22M | 29.84M | 3.38M |
| Intangible assets | 2.08M | 1.92M | 1.78M | 1.60M |
| Other current assets | - | - | - | 0.48M |
| Total liab | 10.28M | 11.93M | 43.65M | 15.06M |
| Total stockholder equity | -3.16M | 35.29M | -13.81M | -11.68M |
| Other current liab | 0.28M | 4.93M | 36.32M | 3.62M |
| Common stock | - | 263.36M | 215.15M | 194.86M |
| Capital stock | 264.51M | 263.36M | 215.82M | 194.86M |
| Retained earnings | -296.43M | -253.89M | -239.03M | -214.84M |
| Other liab | - | 0.06M | - | - |
| Cash | 3.29M | 32.31M | 25.47M | 0.81M |
| Total current liabilities | 8.86M | 10.89M | 42.90M | 15.06M |
| Short long term debt | - | - | 1.89M | - |
| Other stockholder equity | - | 11.75M | 0.67M | - |
| Property plant equipment | - | 1.64M | 1.11M | 0.03M |
| Total current assets | 5.04M | 43.66M | 26.95M | 1.75M |
| Net tangible assets | - | 33.37M | -15.59M | -13.28M |
| Net receivables | 0.00M | 8.28M | 0.07M | 0.08M |
| Accounts payable | - | 5.62M | 4.53M | 10.85M |
| Non current assets total | 2.08M | 3.56M | 2.89M | 1.63M |
| Capital lease obligations | 1.71M | 1.33M | 0.92M | 0.03M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -1.02M | -0.76M | -0.60M | -0.46M |
| Change to liabilities | - | 1.09M | -4.37M | 4.96M |
| Total cashflows from investing activities | - | -0.76M | -0.60M | -0.46M |
| Net borrowings | - | 0.03M | 1.41M | -0.01M |
| Total cash from financing activities | -0.42M | 44.21M | 26.10M | 35.76M |
| Change to operating activities | - | -1.60M | -0.54M | 8.34M |
| Net income | -42.54M | -14.86M | -24.18M | -41.91M |
| Change in cash | -29.02M | 6.84M | 24.66M | -10.66M |
| Begin period cash flow | 32.31M | 25.47M | 0.81M | 11.47M |
| End period cash flow | 3.29M | 32.31M | 25.47M | 0.81M |
| Total cash from operating activities | -27.58M | -36.62M | -0.84M | -45.96M |
| Issuance of capital stock | 0.00M | 34.18M | 24.69M | 35.77M |
| Depreciation | 0.86M | 0.70M | 0.28M | 0.03M |
| Change to account receivables | - | -10.03M | -10.03M | -10.03M |
| Other cashflows from financing activities | - | 9.09M | 9.09M | 9.09M |
| Change to netincome | - | -11.92M | 27.97M | -17.39M |
| Capital expenditures | 1.02M | 0.37M | 0.28M | 0.28M |
| Change in working capital | 12.19M | -10.54M | -4.92M | 13.30M |
| Stock based compensation | 4.08M | 4.04M | 1.10M | 1.65M |
| Other non cash items | 0.13M | -0.35M | -1.08M | 0.74M |
| Free cash flow | -28.60M | -37.37M | -1.44M | -46.42M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories |
-0.71 0.65% |
108.58 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
0.28 0.28% |
101.89 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-2.16 0.68% |
316.63 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
- -% |
47.31 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...